Top Clinical Trials companies in Australia by Operating Income Margin

This ranking features the top 15 Clinical Trials companies in Australia ranked by Operating Income Margin, averaging a Operating Income Margin of -27,370.94%, for February 07, 2025.
#
Name
Operating Income Margin
Reported Date
Stock Price
Change
Price (30 days) Country
1
55.74%
June 30, 2024 USD 7.27 0.71%

Australia

2
12.55%
June 30, 2024 USD 169.95 -0.56%

Australia

3
10.45%
Dec. 31, 2023 USD 18.33 -0.84%

Australia

4
9.31%
June 30, 2024 USD 0.74 1.48%

Australia

5
8.25%
June 30, 2024 USD 2.33 0.08%

Australia

6
1.13%
June 30, 2024 USD 1.23 -0.40%

Australia

7
-2.10%
June 30, 2024 USD 0.74 0.62%

Australia

8
-118.32%
June 30, 2024 USD 2.04 -5.56%

Australia

9
-389.35%
June 30, 2024 USD 2.46 10.79%

Australia

10
-487.69%
June 30, 2024 USD 4.80 5.03%

Australia

11
-1,425.74%
June 30, 2024 USD 1.90 -4.74%

Australia

12
-1,718.11%
Dec. 31, 2023 USD 6.16 2.82%

Australia

13
-2,293.26%
June 30, 2024 USD 2.09 0.97%

Australia

14
-153,885.37%
June 30, 2024 NA

Australia

15
-250,341.67%
June 30, 2024 USD 1.67 2.45%

Australia

Frequently Asked Questions
  • Which Clinical Trials company in Australia has the highest Operating Income Margin ?

    The Clinical Trials company in Australia with the highest Operating Income Margin is Clinuvel Pharmaceuticals Limited (ASX: CUV.AX) at 55.74%.

  • Which Clinical Trials company in Australia has the lowest Operating Income Margin ?

    The Clinical Trials company in Australia with the lowest Operating Income Margin is Incannex Healthcare Limited (NasdaqGM: IXHL) at -250,341.67%.

SV Wall Street